| 供貨周期 |
一周 |
規格 |
凍存管 T25 |
| 應用領域 |
醫療衛生,化工,生物產業,制藥/生物制藥 |
主要用途 |
科學研究 |
CRL-2266 SH-SY5Y 人神經母細胞瘤細胞，原代細胞|細胞系|細胞株|菌種；細胞庫管理規范，提供的細胞株背景清楚，提供參考文獻和培養條件！
產品名稱--人神經母細胞瘤細胞；SH-SY5Y (STR)
英文名--SH-SY5Y (STR)
規格--1×10?cells/T25培養瓶
培養--DMEM+10%FBS
別稱--SH-Sy5y; SHSY5Y; SHSY-5Y; SK-SH-SY5Y; SY5Y; SH-SY5Y Parental
形態特征--上皮樣
生長特性--貼壁生長
培養基--SH-SY5Y完培養基
培養條件--氣相：空氣，95%；CO2,5%溫度：37℃
傳代方法--1：2傳代
組織來源--骨髓
細胞簡介--SH - SY5Y 細胞在神經科學研究領域應用廣泛，常被用于神經退行性疾病、神經發育以及藥物研發等方面的研究，有助于深入了解神經母細胞瘤的發病機制和探索相關治療策略。
特征特性--據報道，該細胞的密度可高達1×106cells/cm2，具有中等水平的多巴胺β羥化酶的活性。
CRL-2266 SH-SY5Y 人神經母細胞瘤細胞
| ATCC® Number: | CRL-2266™ | Price: | |
| Designations: | SH-SY5Y |
|
| | Depositors: | JL Biedler |
|
| | Biosafety Level: | 1 |
|
| | Shipped: | frozen |
|
| | Medium & Serum: | See Propagation |
|
| | Growth Properties: | mixed, adherent and suspension |
|
| | Organism: | Homo sapiens （human） |
|
| | Morphology: | epithelial
|
|
| | Source: | Organ: brain
Disease: neuroblastoma
Derived from metastatic site: bone marrow |
|
| | Permits/Forms: | In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. | | CRL-2266 SH-SY5Y 人神經母細胞瘤細胞 |
|
| | Restrictions: | NOTE: SH-SY5Y was deposited at the ATCC by June L. Biedler, Memorial Sloan-Kettering Cancer Center. SH-SY5Y is distributed for academic research purposes only. Memorial Sloan-Kettering releases the line subject to the following: 1.） SH-SY5Y or its products must not be distributed to third parties. Commercial interests are the exclusive property of Memorial Sloan-Kettering Cancer Center. 2.） Any proposed commercial use of SH-SY5Y including any use by a for-profit entity must first be negotiated with Director, Office of Industrial Affairs, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021; phone （212） 639-6181; （212） 717-3439. |
|
| | Isolation: | Isolation date: 1970 |
|
| | Applications: | transfection host （Roche FuGENE® Transfection Reagents technology from amaxa） |
|
| | Antigen Expression: | Blood Type A; Rh+ |
|
| | DNA Profile （STR）: | Amelogenin: X CSF1PO: 11 D13S317: 11 D16S539: 8,13 D5S818: 12 D7S820: 7,10 THO1: 7,10 TPOX: 8,11 vWA: 14,18 |
|
| | Cytogenetic Analysis: | modal number = 47; the cells possess a unique marker comprised of a chromosome 1 with a complex insertion of an additional copy of a 1q segment into the long arm, resulting in trisomy of 1q [22554] |
|
| | Age: | 4 years |
|
| | Gender: | female |
|
| | Comments: | SH-SY5Y cells have a reported saturation density greater than 1 X 10（6） cells/sq cm. They are reported to exhibit moderate levels of dopamine beta hydroxylase activity [PubMed ID: 29704]. |
|
| | Propagation: | ATCC complete growth medium: The base medium for this cell line is a 1:1 mixture of ATCC-formulated Eagle's Minimum Essential Medium, Catalog No. 30-2003, and F12 Medium. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%. Atmosphere: air, 95%; carbon dioxide （CO2）, 5%
Temperature: 37.0°C |
|
| | Subculturing: |
|
|
| | Doubling Time: | 48 hrs |
|
| | Related Products: | recommended serum:ATCC 30-2020 parental cell line:ATCC HTB-11 |
|
| | References: | 22554: Ross RA, et al. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer Inst. 71: 741-749, 1983. PubMed: 6137586 23032: Biedler JL, et al. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38: 3751-3757, 1978. PubMed: 29704 |
|
|
15
